{"id":"panadol","safety":{"commonSideEffects":[{"rate":null,"effect":"Hepatotoxicity (at overdose)"},{"rate":"rare","effect":"Rash"},{"rate":"rare","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL112","moleculeType":"Small molecule","molecularWeight":"151.16"},"_dailymed":{"setId":"fa0ce51f-441d-4409-8617-b3402b00f187","title":"PANADOL COLD AND FLU NONDROWSY (ACETAMINOPHEN AND PHENYLEPRINE HCL) TABLET, FILM COATED [HALEON US HOLDINGS LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Paracetamol works primarily through inhibition of cyclooxygenase (COX) enzymes in the brain and spinal cord, reducing prostaglandin production and lowering the pain threshold and fever set point. Unlike NSAIDs, it has minimal peripheral anti-inflammatory effects and does not significantly inhibit COX in peripheral tissues, making it gentler on the gastrointestinal tract and cardiovascular system.","oneSentence":"Panadol (paracetamol/acetaminophen) reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:43:48.939Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mild to moderate pain"},{"name":"Fever reduction"},{"name":"Headache"},{"name":"Muscular aches"}]},"trialDetails":[{"nctId":"NCT06841354","phase":"PHASE3","title":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-16","conditions":"Triple Negative Breast Neoplasms","enrollment":1000},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT06170788","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-15","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":614},{"nctId":"NCT06393374","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-24","conditions":"Triple-Negative Breast Cancer","enrollment":1530},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT07486089","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer, Triple-Negative Breast Cancer (TNBC)","enrollment":60},{"nctId":"NCT07216703","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-19","conditions":"Cervical Cancer","enrollment":1023},{"nctId":"NCT06043323","phase":"PHASE2","title":"A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-01-08","conditions":"Follicular Lymphoma","enrollment":20},{"nctId":"NCT06780111","phase":"PHASE1, PHASE2","title":"Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-30","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":298},{"nctId":"NCT05807048","phase":"PHASE2","title":"Daratumumab in STK11 Mutated NSCLC","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-06-01","conditions":"Non-small Cell Lung Cancer With STK11/LKB1 Mutation","enrollment":8},{"nctId":"NCT06788912","phase":"PHASE2","title":"Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-20","conditions":"Lung Neoplasm Malignant","enrollment":60},{"nctId":"NCT07401134","phase":"PHASE4","title":"Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery","status":"RECRUITING","sponsor":"University of Miami","startDate":"2026-02-18","conditions":"Perineal Injury, Pain Vulva, Perineum; Injury","enrollment":70},{"nctId":"NCT06089291","phase":"","title":"Persona IQ Cohort Study","status":"ENROLLING_BY_INVITATION","sponsor":"Zimmer Biomet","startDate":"2024-02-20","conditions":"Osteo Arthritis Knee, Knee Arthritis, Monitoring Orthopedic Devices","enrollment":200},{"nctId":"NCT06074588","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-12","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":556},{"nctId":"NCT03913559","phase":"PHASE2","title":"Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-05-14","conditions":"Acute Lymphoblastic Leukemia","enrollment":5},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT05144828","phase":"PHASE4","title":"Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2022-02-15","conditions":"Pain, Postoperative, Lung Diseases","enrollment":33},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT06647407","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-05","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":750},{"nctId":"NCT06132958","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-06","conditions":"Endometrial Cancer","enrollment":710},{"nctId":"NCT06460961","phase":"PHASE1","title":"A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-14","conditions":"Neoplasm Metastasis","enrollment":168},{"nctId":"NCT06298227","phase":"NA","title":"Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy","status":"RECRUITING","sponsor":"Istanbul Medipol University Hospital","startDate":"2024-03-11","conditions":"Kidney Diseases, Kidney Failure","enrollment":60},{"nctId":"NCT04702256","phase":"PHASE3","title":"Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-12-09","conditions":"Lupus Nephritis, Systemic Lupus Erythematosus (SLE)","enrollment":196},{"nctId":"NCT05405166","phase":"PHASE3","title":"SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2022-06-23","conditions":"Plasma Cell Myeloma Recurrent","enrollment":531},{"nctId":"NCT07225634","phase":"PHASE3","title":"A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain","status":"NOT_YET_RECRUITING","sponsor":"AFT Pharmaceuticals, Ltd.","startDate":"2026-02","conditions":"Acute Pain","enrollment":60},{"nctId":"NCT07225140","phase":"PHASE3","title":"A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery","status":"NOT_YET_RECRUITING","sponsor":"AFT Pharmaceuticals, Ltd.","startDate":"2026-02","conditions":"Post Operative Pain, Acute","enrollment":180},{"nctId":"NCT05285813","phase":"PHASE2","title":"A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-05-06","conditions":"AML, MDS","enrollment":42},{"nctId":"NCT07173231","phase":"NA","title":"Use of VR for Diagnostic Hysteroscopy","status":"NOT_YET_RECRUITING","sponsor":"St. Justine's Hospital","startDate":"2025-11","conditions":"Hysteroscopy, Anxiety, Pain","enrollment":45},{"nctId":"NCT05002959","phase":"","title":"TESS V3 Modular Total Shoulder System PMCF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zimmer Biomet","startDate":"2022-02-01","conditions":"Osteoarthritis Shoulder, Rheumatoid Arthritis, Rheumatoid Arthritis Shoulder","enrollment":67},{"nctId":"NCT05834569","phase":"PHASE4","title":"Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients","status":"TERMINATED","sponsor":"Korea University Guro Hospital","startDate":"2023-06-15","conditions":"Delirium, Aged, Lung Neoplasms","enrollment":25},{"nctId":"NCT01810588","phase":"PHASE2","title":"Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-16","conditions":"Hematologic Malignancies","enrollment":270},{"nctId":"NCT04688788","phase":"PHASE3","title":"Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-04-28","conditions":"Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis","enrollment":600},{"nctId":"NCT04165096","phase":"PHASE2","title":"KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-01-21","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":128},{"nctId":"NCT06479122","phase":"PHASE4","title":"Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-10-09","conditions":"Cesarean Section, Postoperative Pain","enrollment":84},{"nctId":"NCT06979206","phase":"NA","title":"Effects of Binaural Beats on Inhaled Anesthetic Requirements During General Anesthesia in Pediatric Patients","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-05-30","conditions":"General Anesthesia, Children","enrollment":68},{"nctId":"NCT04230252","phase":"PHASE1","title":"A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2020-01-07","conditions":"Healthy","enrollment":30},{"nctId":"NCT04214691","phase":"PHASE1","title":"A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2019-12-17","conditions":"Healthy","enrollment":30},{"nctId":"NCT06778629","phase":"NA","title":"Transversalis Fascia Plane Block for Laparoscopic Inguinal Hernia Repair","status":"RECRUITING","sponsor":"Istanbul Medipol University Hospital","startDate":"2025-02-14","conditions":"Laparoscopic Inguinal Hernia Repair, Acute Post Operative Pain","enrollment":60},{"nctId":"NCT06286254","phase":"","title":"Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-09-20","conditions":"Acute Respiratory Viral Infection","enrollment":742},{"nctId":"NCT02904551","phase":"NA","title":"Gingival Augmentation Around Implants During Maintenance","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2012-02","conditions":"Failure of Dental Implant Due to Lack of Attached Gingiva","enrollment":30},{"nctId":"NCT01938261","phase":"PHASE2","title":"The Preterm Infants' Paracetamol Study","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2013-08","conditions":"Persistent Ductus Arteriosus, Complication of Prematurity, Pain or Discomfort in Intensive Care of Preterm Infants","enrollment":120},{"nctId":"NCT06637683","phase":"NA","title":"Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2019-11-15","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT03888807","phase":"PHASE4","title":"Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain","status":"TERMINATED","sponsor":"Sport and Spine Rehab Clinical Research Foundation","startDate":"2018-03-01","conditions":"Knee Osteoarthritis","enrollment":6},{"nctId":"NCT03635957","phase":"PHASE4","title":"Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout","status":"COMPLETED","sponsor":"Amgen","startDate":"2018-09-26","conditions":"Gout","enrollment":14},{"nctId":"NCT03994731","phase":"PHASE4","title":"Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout","status":"COMPLETED","sponsor":"Amgen","startDate":"2019-06-13","conditions":"Gout","enrollment":152},{"nctId":"NCT03947671","phase":"PHASE2","title":"Active Temperature Management After Cardiac Surgery and Its Effect on Postoperative Cognitive Dysfunction","status":"WITHDRAWN","sponsor":"Virginia Commonwealth University","startDate":"2020-01-22","conditions":"Cardiac Surgery, Post-operative Cognitive Dysfunction, Fever","enrollment":""},{"nctId":"NCT05563961","phase":"NA","title":"A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers","status":"UNKNOWN","sponsor":"Sinew Pharma Inc.","startDate":"2022-10-28","conditions":"Hepatitis, Pharmacology","enrollment":48},{"nctId":"NCT05557448","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose","status":"RECRUITING","sponsor":"Sinew Pharma Inc.","startDate":"2023-05-01","conditions":"Hepatitis","enrollment":24},{"nctId":"NCT06180070","phase":"PHASE1","title":"Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2023-08-29","conditions":"Migraine, Headache, Backache","enrollment":36},{"nctId":"NCT04488926","phase":"PHASE4","title":"Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients","status":"COMPLETED","sponsor":"Epitech Group SpA","startDate":"2020-07-16","conditions":"Fibromyalgia","enrollment":21},{"nctId":"NCT03451487","phase":"NA","title":"A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study","status":"COMPLETED","sponsor":"Sinew Pharma Inc.","startDate":"2022-05-19","conditions":"Acetaminophen Toxicity","enrollment":28},{"nctId":"NCT05863221","phase":"PHASE4","title":"ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy","status":"UNKNOWN","sponsor":"Dr. Yannis Raftopoulos","startDate":"2023-05-09","conditions":"Post Operative Pain, Acute, Bariatric Surgery Candidate, Postoperative Pain","enrollment":120},{"nctId":"NCT05602064","phase":"PHASE4","title":"Effectiveness of Pre-emptive Analgesics on Post-Operative Pain After Stainless Steel Crown Placement On Primary Molars","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-11-01","conditions":"Post-operative Pain","enrollment":66},{"nctId":"NCT01086540","phase":"PHASE2","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-06-24","conditions":"Systemic Sclerosis-Associated PAH","enrollment":57},{"nctId":"NCT05222724","phase":"PHASE4","title":"Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back Pain","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2021-12-01","conditions":"Low Back Pain","enrollment":176},{"nctId":"NCT04920838","phase":"PHASE2, PHASE3","title":"Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection","status":"UNKNOWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2021-04-12","conditions":"Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":600},{"nctId":"NCT04997785","phase":"NA","title":"PENG Block for Traumatic Hip Fracture in the Emergency Department","status":"COMPLETED","sponsor":"Dalin Tzu Chi General Hospital","startDate":"2021-08-30","conditions":"Hip Fractures, Acute Pain, Emergency Department","enrollment":65},{"nctId":"NCT05557344","phase":"PHASE4","title":"Oral vs IV Acetaminophen for Long-bone Fracture in Children","status":"UNKNOWN","sponsor":"Dr. Niina Kleiber","startDate":"2021-04-21","conditions":"Pain","enrollment":20},{"nctId":"NCT04903509","phase":"PHASE1","title":"A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-06-08","conditions":"Healthy","enrollment":95},{"nctId":"NCT02495077","phase":"PHASE2","title":"Effects of Inhibiting Early Inflammation in Kidney Transplant Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-11-02","conditions":"Kidney Transplant","enrollment":290},{"nctId":"NCT05428293","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral Suspension","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2019-02-22","conditions":"Healthy","enrollment":42},{"nctId":"NCT05428306","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2018-10-23","conditions":"Healthy","enrollment":42},{"nctId":"NCT05417997","phase":"PHASE3","title":"Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients","status":"COMPLETED","sponsor":"RAAS Nutritionals, LLC","startDate":"2021-05-29","conditions":"COVID-19 Respiratory Infection, FLU, Cold; Influenza","enrollment":71},{"nctId":"NCT04096391","phase":"NA","title":"Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population","status":"COMPLETED","sponsor":"Evolve Restorative Center","startDate":"2019-06-05","conditions":"Chronic Nonmalignant Pain, Pain, Intractable, Pain, Chronic","enrollment":73},{"nctId":"NCT05237596","phase":"","title":"Prescription-grade Crystalline Glucosamine Sulfate Therapy in Erosive Hand Osteoarthritis","status":"COMPLETED","sponsor":"University of Siena","startDate":"2021-01-07","conditions":"Erosive Osteoarthritis of the Hand","enrollment":123},{"nctId":"NCT04899401","phase":"NA","title":"Trial To Assess Efficacy and Safety of PediaFlu® in Children With Acute Tonsillopharyngitis / Rhinopharyngitis","status":"COMPLETED","sponsor":"Pediatrica S.r.l","startDate":"2021-06-03","conditions":"Tonsillopharyngitis, Rhinopharyngitis","enrollment":130},{"nctId":"NCT04005755","phase":"PHASE3","title":"Maxigesic® IV Phase 3 Exposure Study","status":"COMPLETED","sponsor":"AFT Pharmaceuticals, Ltd.","startDate":"2019-07-22","conditions":"Postoperative Pain","enrollment":232},{"nctId":"NCT00324467","phase":"PHASE2","title":"Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment","status":"UNKNOWN","sponsor":"British Columbia Cancer Agency","startDate":"2006-08","conditions":"Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma","enrollment":150},{"nctId":"NCT01500109","phase":"NA","title":"Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2011-11","conditions":"Cleft Palate","enrollment":45},{"nctId":"NCT04185714","phase":"NA","title":"THE EFFECTS OF KINESIO®TAPING IN PATIENTS WITH MIGRAINE","status":"COMPLETED","sponsor":"Medipol University","startDate":"2020-01-01","conditions":"Migraine, Pain","enrollment":60},{"nctId":"NCT01880125","phase":"PHASE1","title":"Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination","status":"COMPLETED","sponsor":"Yungjin Pharm. Co., Ltd.","startDate":"2012-01","conditions":"Pain","enrollment":24},{"nctId":"NCT03804047","phase":"NA","title":"KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis","status":"UNKNOWN","sponsor":"Northern Illinois University","startDate":"2019-01-01","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT02890810","phase":"NA","title":"Predicting Analgesic Response to Acupuncture: A Practical Approach","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-07","conditions":"Chronic Low Back Pain, Back Pain","enrollment":121},{"nctId":"NCT02786836","phase":"PHASE2, PHASE3","title":"13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-06-10","conditions":"Acute Liver Failure","enrollment":76},{"nctId":"NCT02188719","phase":"PHASE1","title":"Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-12-17","conditions":"Liver Transplantation","enrollment":15},{"nctId":"NCT02985671","phase":"PHASE3","title":"To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.","status":"UNKNOWN","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2021-01","conditions":"Postural Low Back Pain, Mechanical Low Back Pain","enrollment":110},{"nctId":"NCT04265456","phase":"PHASE1","title":"A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers","status":"COMPLETED","sponsor":"Nevakar, Inc.","startDate":"2020-01-14","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT02508935","phase":"PHASE4","title":"Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain","status":"TERMINATED","sponsor":"Mallinckrodt","startDate":"2015-11-20","conditions":"Acute Pain","enrollment":23},{"nctId":"NCT03343392","phase":"PHASE3","title":"The Effect of Different Drugs in the Prevention of Tooth Sensitivity Caused by Tooth Bleaching Treatment.","status":"COMPLETED","sponsor":"Universidade Estadual de Ponta Grossa","startDate":"2017-11-05","conditions":"Hydrogen Peroxide Allergy","enrollment":114},{"nctId":"NCT03157349","phase":"NA","title":"Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion","status":"COMPLETED","sponsor":"Sport and Spine Rehab Clinical Research Foundation","startDate":"2017-03-01","conditions":"Acute Pain, Neck Pain","enrollment":59},{"nctId":"NCT01485094","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain","status":"TERMINATED","sponsor":"Grünenthal GmbH","startDate":"2012-02","conditions":"Neuralgia","enrollment":114},{"nctId":"NCT02241148","phase":"NA","title":"Close Kinetic Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome","status":"TERMINATED","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2014-02","conditions":"Patellofemoral Pain Syndrome","enrollment":15},{"nctId":"NCT03554005","phase":"PHASE1","title":"Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1997-12-29","conditions":"Neoplasms","enrollment":29},{"nctId":"NCT03996564","phase":"NA","title":"Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department","status":"COMPLETED","sponsor":"San Antonio Military Medical Center","startDate":"2016-02-22","conditions":"Low Back Pain, Mechanical","enrollment":26},{"nctId":"NCT03315923","phase":"PHASE2, PHASE3","title":"Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2017-12-01","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":84},{"nctId":"NCT03585374","phase":"PHASE3","title":"Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)","status":"COMPLETED","sponsor":"Mundipharma Pharmaceuticals srl","startDate":"2018-02-08","conditions":"Acute Traumatic Pain","enrollment":272},{"nctId":"NCT03567941","phase":"PHASE1","title":"To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen","status":"COMPLETED","sponsor":"Sun Pharma Advanced Research Company Limited","startDate":"2017-12-29","conditions":"Healthy","enrollment":32},{"nctId":"NCT02582996","phase":"PHASE3","title":"Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks","status":"SUSPENDED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2020-04","conditions":"Migraine","enrollment":336},{"nctId":"NCT03888820","phase":"PHASE4","title":"Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sport and Spine Rehab Clinical Research Foundation","startDate":"2018-03-01","conditions":"Chronic Low Back Pain","enrollment":20},{"nctId":"NCT03051932","phase":"NA","title":"Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2018-06-01","conditions":"Post-thoracotomy Pain Syndrome","enrollment":""},{"nctId":"NCT02963701","phase":"PHASE1","title":"Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-12-20","conditions":"Healthy Volunteers","enrollment":56},{"nctId":"NCT03385057","phase":"PHASE1","title":"Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy","status":"WITHDRAWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2018-09","conditions":"Tonsillectomy With or Without Adenoidectomy","enrollment":""},{"nctId":"NCT03517930","phase":"PHASE1","title":"A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-17","conditions":"Clinical Pharmacology","enrollment":52},{"nctId":"NCT01229449","phase":"PHASE3","title":"Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study","status":"COMPLETED","sponsor":"Reckitt Benckiser LLC","startDate":"2009-01","conditions":"Post-operative Pain","enrollment":678},{"nctId":"NCT03517943","phase":"PHASE1","title":"A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-24","conditions":"Clinical Pharmacology","enrollment":29},{"nctId":"NCT01170637","phase":"PHASE1","title":"Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2010-07","conditions":"Healthy","enrollment":47},{"nctId":"NCT02504775","phase":"NA","title":"Bioequivalence Study for Mejoral 500 Product","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-08-01","conditions":"Pain","enrollment":28},{"nctId":"NCT01745913","phase":"PHASE2","title":"Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-26","conditions":"Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia","enrollment":2},{"nctId":"NCT03262805","phase":"NA","title":"To Assess the Lanconone® (E-OA-07) Efficacy in Physical Activity-related Pain- LEAP Study","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2017-08-28","conditions":"Knee Osteoarthritis","enrollment":73}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Acetaminophen"],"phase":"marketed","status":"active","brandName":"Panadol®","genericName":"Panadol®","companyName":"Sinew Pharma Inc.","companyId":"sinew-pharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Panadol (paracetamol/acetaminophen) reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. Used for Mild to moderate pain, Fever reduction, Headache.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}